ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,969.34
0.35%
Dow Jones
44,296.51
0.97%
US Dollar vs MXN
20.4285
0.00%
Brent Oil
74.65
0.00%
Bitcoin
97,958.13
0.18%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. N4 Pharma Plc (N4P)

  7. N4 Pharma Plc (N4P) Noticias

N4P

N4 Pharma (N4P)

N4 Pharma Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:N4P
FechaHoraFuenteTítuloSímboloCompañía
01/11/202402:00RNS Non-RegulatoryN4 Pharma PLC N4 Pharma CEO Q&A Now LIVELSE:N4PN4 Pharma Plc
24/10/202401:00RNS Non-RegulatoryN4 Pharma PLC New Corporate PresentationLSE:N4PN4 Pharma Plc
24/09/202409:01Alliance NewsAlliance NewsEARNINGS: Metals One advances Black Schist, N4 generates revenueLSE:N4PN4 Pharma Plc
24/09/202401:00RNS Regulatory NewsN4 Pharma PLC Interim ResultsLSE:N4PN4 Pharma Plc
17/09/202402:04RNS Regulatory NewsN4 Pharma PLC SRI Research UpdateLSE:N4PN4 Pharma Plc
09/09/202401:00RNS Regulatory NewsN4 Pharma PLC Director AppointmentLSE:N4PN4 Pharma Plc
23/08/202402:30RNS Regulatory NewsN4 Pharma PLC Change of AuditorLSE:N4PN4 Pharma Plc
20/08/202405:52Alliance NewsAlliance NewsIN BRIEF: N4 Pharma celebrates chemistry work update on NuvecLSE:N4PN4 Pharma Plc
03/07/202406:09Alliance NewsAlliance NewsTRADING UPDATES: Topps Tiles sales dip; Physiomics completes placingLSE:N4PN4 Pharma Plc
03/07/202401:00RNS Regulatory NewsN4 Pharma PLC Nanogenics UpdateLSE:N4PN4 Pharma Plc
28/06/202401:00RNS Regulatory NewsN4 Pharma PLC Total Voting RightsLSE:N4PN4 Pharma Plc
19/06/202401:00RNS Regulatory NewsN4 Pharma PLC Holding(s) in CompanyLSE:N4PN4 Pharma Plc
07/06/202406:32Alliance NewsAlliance NewsN4 Pharma raises GBP630,000 to advance primary work streamsLSE:N4PN4 Pharma Plc
07/06/202404:18RNS Regulatory NewsN4 Pharma PLC Placing and Subscription to raise £630,000LSE:N4PN4 Pharma Plc
23/05/202406:19RNS Regulatory NewsN4 Pharma PLC Result of AGMLSE:N4PN4 Pharma Plc
29/04/202404:59RNS Regulatory NewsN4 Pharma PLC Posting of Annual Report & Notice of AGMLSE:N4PN4 Pharma Plc
26/04/202401:00RNS Non-RegulatoryN4 Pharma PLC N4 Pharma Webinar on SRI CollaborationLSE:N4PN4 Pharma Plc
25/04/202405:56Alliance NewsAlliance NewsN4 Pharma strikes partnership deal for intracellular deliveryLSE:N4PN4 Pharma Plc
25/04/202401:38RNS Regulatory NewsN4 Pharma PLC Collaboration Agreement with SRI International IncLSE:N4PN4 Pharma Plc
23/04/202407:32Alliance NewsAlliance NewsIN BRIEF: N4 Pharma loss widens but "great optimism" remainsLSE:N4PN4 Pharma Plc
23/04/202401:00RNS Regulatory NewsN4 Pharma PLC Final ResultsLSE:N4PN4 Pharma Plc
18/04/202406:14Alliance NewsAlliance NewsN4 Pharma sees potential in Nuvec delivery method for cancer treatmentLSE:N4PN4 Pharma Plc
18/04/202401:00RNS Regulatory NewsN4 Pharma PLC Oral Delivery UpdateLSE:N4PN4 Pharma Plc
15/02/202406:06Alliance NewsAlliance NewsIN BRIEF: N4 Pharma shares rise on "encouraging" Nuvec researchLSE:N4PN4 Pharma Plc
15/02/202401:00RNS Regulatory NewsN4 Pharma PLC in-vitro siRNA updateLSE:N4PN4 Pharma Plc
19/01/202403:26Alliance NewsAlliance NewsIN BRIEF: N4 Pharma gets India patent for medical delivery systemLSE:N4PN4 Pharma Plc
19/01/202401:00UK RegulatoryN4 Pharma PLC Patent GrantLSE:N4PN4 Pharma Plc
16/01/202407:26Alliance NewsAlliance NewsIN BRIEF: N4 Pharma touts contract to test glaucoma treatment, ECP105LSE:N4PN4 Pharma Plc
08/01/202403:11Alliance NewsAlliance NewsN4 Pharma hails increased efficacy of Nuvec when complexed with AAV8LSE:N4PN4 Pharma Plc
08/01/202401:00UK RegulatoryN4 Pharma PLC AAV Viral Vector UpdateLSE:N4PN4 Pharma Plc
 Showing the most relevant articles for your search:LSE:N4P

Su Consulta Reciente

AQSE
PSY
Shortwave Life Sciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados